MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer

BACKGROUND AND PURPOSE: Locally recurrent prostate cancer after radiotherapy merits an effective salvage strategy that mitigates the risk of adverse events. We report outcomes of a cohort enrolled across two institutions investigating MRI-guided tumor-targeted salvage high dose rate brachytherapy (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Ménard, Cynthia, Navarro-Domenech, Inmaculada, Liu, Zhihu (Amy), Joseph, Lisa, Barkati, Maroie, Berlin, Alejandro, Delouya, Guila, Taussky, Daniel, Beauchemin, Marie-Claude, Nicolas, Benedicte, Kadoury, Samuel, Rink, Alexandra, Raman, Srinivas, Sundaramurthy, Aravindhan, Weersink, Robert, Beliveau-Nadeau, Dominic, Helou, Joelle, Chung, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459480/
https://www.ncbi.nlm.nih.gov/pubmed/36091157
http://dx.doi.org/10.3389/fonc.2022.971344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459480/
https://www.ncbi.nlm.nih.gov/pubmed/36091157
http://dx.doi.org/10.3389/fonc.2022.971344

Ejemplares similares